Cameron Haswell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cameron Haswell has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ajmol Ali
School of Sport, Exercise and Nutrition, Massey University, Auckland 0745, New Zealand
2 shared publications - Kay Rutherfurd-Markwick
School of Health Sciences, Massey University, Auckland 0632, New Zealand
2 shared publications - Rachel Page
School of Health Sciences, Massey University, Wellington 6140, New Zealand
2 shared publications - Roger D. Hurst
Ag Emissions Centre, Bioeconomy Science Institute, Palmerston North 4442, New Zealand
2 shared publications - Hajar Mazahery
Curtin School of Population Health, Curtin University, Perth, WA 6102, Australia
1 shared publication - Marie Wong
School of Food and Advanced Technology, Massey University, Auckland 0745, New Zealand
1 shared publication
Latest Publications
- Open Access
- 17 August 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (8) , 579
Effects of Nitrate- and Betalain-Rich Beetroot Juice Ingestion on Vascular Function and Metabolic Syndrome Risk Factors in Healthy Adults: A Pilot Study
Background/Objectives: Health challenges associated with metabolic syndrome (MetS) have stimulated investigations into the effectiveness of nutraceutical interventions, including beetroot juice (BRJ), in mitigating MetS risk factors. Methods: This repeated-measures crossover trial (n = 16 healthy participants) investigates the effects of daily ingestion of two different BRJs [United Kingdom beetroot juice (UKBR), 1280 mg nitrate, 147 mg betalains; New Zealand beetroot juice (NZBR), 1120 mg nitrate, 506 mg betalains] and placebo (PL) on plasma nitrate and nitrite levels, MetS biomarkers and systemic vascular resistance (SVR). Participants consumed the juices for 6 days, with measures taken on day 7 fasted (pre-dose) and 2 h and 5 h post ingestion (acute). Results: On day 7, pre-dose plasma nitrate levels were significantly elevated for UKBR and NZBR compared to PL (297.2, 177.1 and 64.2 µmol/L, respectively). On day 7, UKBR achieved significantly higher plasma nitrate levels 2 h and 5 h post consumption than NZBR (2 h: 750.3 vs. 577.7 µmol/L; 5 h: 703.4 vs. 510.1 µmol/L) and PL at all timepoints. Plasma nitrite was elevated pre-dose for UKBR only and for both juices relative to PL at 2 h and 5 h. On day 7, pre-dose systolic blood pressure (SBP) was significantly lower for NZBR than PL (−4.96 mmHg) and 2 h post-ingestion for both UKBR (−5.63 mmHg) and NZBR (−4.98 mmHg) compared with PL. Systemic vascular resistance was 11.6% lower after 6 days of consumption of NZBR relative to PL (ratio 0.884, 95% CI 0.803 to 0.974). Conclusions: Supplementation with BRJ reduced SBP relative to placebo, and the betalain-rich NZBR also reduced SVR, whereas the higher-nitrate UKBR did not. This suggests that betalains and nitrates may play an important role in these improvements. The Australia New Zealand Clinical Trials Registry ID for this study is: ACTRN12622000714785.
- 17 August 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (8) , 579
Open AccessEffects of Nitrate- and Betalain-Rich Beetroot Juice Ingestion on Vascular Function and Metabolic Syndrome Risk Factors in Healthy Adults: A Pilot Study
Background/Objectives: Health challenges associated with metabolic syndrome (MetS) have stimulated investigations into the effectiveness of nutraceutical interventions, including beetroot juice (BRJ), in mitigating MetS risk factors. Methods: This repeated-measures crossover trial (n = 16 healthy participants) investigates the effects of daily ingestion of two different BRJs [United Kingdom beetroot juice (UKBR), 1280 mg nitrate, 147 mg betalains; New Zealand beetroot juice (NZBR), 1120 mg nitrate, 506 mg betalains] and placebo (PL) on plasma nitrate and nitrite levels, MetS biomarkers and systemic vascular resistance (SVR). Participants consumed the juices for 6 days, with measures taken on day 7 fasted (pre-dose) and 2 h and 5 h post ingestion (acute). Results: On day 7, pre-dose plasma nitrate levels were significantly elevated for UKBR and NZBR compared to PL (297.2, 177.1 and 64.2 µmol/L, respectively). On day 7, UKBR achieved significantly higher plasma nitrate levels 2 h and 5 h post consumption than NZBR (2 h: 750.3 vs. 577.7 µmol/L; 5 h: 703.4 vs. 510.1 µmol/L) and PL at all timepoints. Plasma nitrite was elevated pre-dose for UKBR only and for both juices relative to PL at 2 h and 5 h. On day 7, pre-dose systolic blood pressure (SBP) was significantly lower for NZBR than PL (−4.96 mmHg) and 2 h post-ingestion for both UKBR (−5.63 mmHg) and NZBR (−4.98 mmHg) compared with PL. Systemic vascular resistance was 11.6% lower after 6 days of consumption of NZBR relative to PL (ratio 0.884, 95% CI 0.803 to 0.974). Conclusions: Supplementation with BRJ reduced SBP relative to placebo, and the betalain-rich NZBR also reduced SVR, whereas the higher-nitrate UKBR did not. This suggests that betalains and nitrates may play an important role in these improvements. The Australia New Zealand Clinical Trials Registry ID for this study is: ACTRN12622000714785.
- 10 July 2022
- Published by Morressier GmbH
Acute supplementation of beetroot but not blackcurrant juice manages postprandial blood glucose responses in healthy adults.
Introduction Currently, more than 463 million people are living with diabetes; a number predicted to rise to 578 million by 20301. As type 2 diab |
- 10 July 2022
- Published by Morressier GmbH
Acute supplementation of beetroot but not blackcurrant juice manages postprandial blood glucose responses in healthy adults.
Introduction Currently, more than 463 million people are living with diabetes; a number predicted to rise to 578 million by 20301. As type 2 diab |
- Open Access
- 25 May 2021
- Published by MDPI AG in Metabolites
- Vol. 11 (6) , 338
Potential of Beetroot and Blackcurrant Compounds to Improve Metabolic Syndrome Risk Factors
Metabolic syndrome (MetS) is a group of metabolic abnormalities, which together lead to increased risk of coronary heart disease (CHD) and type 2 diabetes mellitus (T2DM), as well as reduced quality of life. Dietary nitrate, betalains and anthocyanins may improve risk factors for MetS and reduce the risk of development of CHD and T2DM. Beetroot is a rich source of dietary nitrate, and anthocyanins are present in high concentrations in blackcurrants. This narrative review considers the efficacy of beetroot and blackcurrant compounds as potential agents to improve MetS risk factors, which could lead to decreased risk of CHD and T2DM. Further research is needed to establish the mechanisms through which these outcomes may occur, and chronic supplementation studies in humans may corroborate promising findings from animal models and acute human trials.
- 25 May 2021
- Published by MDPI AG in Metabolites
- Vol. 11 (6) , 338
Open AccessPotential of Beetroot and Blackcurrant Compounds to Improve Metabolic Syndrome Risk Factors
Metabolic syndrome (MetS) is a group of metabolic abnormalities, which together lead to increased risk of coronary heart disease (CHD) and type 2 diabetes mellitus (T2DM), as well as reduced quality of life. Dietary nitrate, betalains and anthocyanins may improve risk factors for MetS and reduce the risk of development of CHD and T2DM. Beetroot is a rich source of dietary nitrate, and anthocyanins are present in high concentrations in blackcurrants. This narrative review considers the efficacy of beetroot and blackcurrant compounds as potential agents to improve MetS risk factors, which could lead to decreased risk of CHD and T2DM. Further research is needed to establish the mechanisms through which these outcomes may occur, and chronic supplementation studies in humans may corroborate promising findings from animal models and acute human trials.